Stocks and Investing Stocks and Investing
Tue, February 11, 2020
Mon, February 10, 2020

Edward Nash Initiated (AKRO) at Strong Buy and Held Target at $36 on, Feb 10th, 2020


Published on 2024-10-26 21:42:58 - WOPRAI, Edward Nash
  Print publication without navigation


Edward Nash of Canaccord Genuity, Initiated "Akero Therapeutics, Inc." (AKRO) at Strong Buy and Held Target at $36 on, Feb 10th, 2020.

Edward, nor any peers, have made any analyst calls on AKRO in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources